๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of chronic hepatitis C patients with amantadine

โœ Scribed by Michiyasu Yagura; Hideharu Harada


Publisher
Springer Japan
Year
2001
Tongue
English
Weight
76 KB
Volume
36
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Re-treatment with interferon alfa of pat
โœ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB ๐Ÿ‘ 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

Treatment of chronic hepatitis C in hemo
โœ Teresa Casanovas ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 1 views

Our algorithm cannot be directly applied to other populations directly because clinical backgrounds differ among countries. However, we think that our study is applicable on a global scale because it has clearly shown that a combination of viral and host factors is effective for predicting the respo

Treatment of chronic hepatitis C in hemo
โœ Marina Berenguer ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 417 KB ๐Ÿ‘ 1 views

Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the d

DDB treatment of patients with chronic h
โœ Roman Huber; Birgit Hockenjos; Hubert E. Blum ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 1 views

We report 13 patients (10 with chronic hepatitis C, 1 with chronic hepatitis B, 2 with nonalcoholic steatohepatitis) with persistently elevated alanine aminotransferase (ALT) levels who were treated with dimethyl-4,4-dimethoxy-5,6,5,6-dimethylenedioxybiphenyl-2,2 dicarboxylate (DDB). ALT rapidly nor